Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by Zibo510on Jan 02, 2024 10:19am
108 Views
Post# 35806953

RE:RE:RE:Before the roof fell in

RE:RE:RE:Before the roof fell in Mr. Seckler was appointed CEO end of July this year, he stated his mandate was profitably, efficiency and increased margins, for the short time he has been in charge he has done a very good job IMO, I think we're in good hands going forward. 



I have worked hard to implement major and rapid change with the goal of achieving profitability this quarter,” said Mike Seckler, CEO. “After restructuring debt and cutting costs, I plan to conduct a strategic review with an aim to put us back on a path to revenue growth and achieve a market multiple consistent with our peers thereby increasing our share price. We have a sizable revenue base, solid product offerings and reasonable gross margins in this vast and growing healthcare market, all attributes that can serve to build a stronger and more focused business.”

<< Previous
Bullboard Posts
Next >>